01 1Emcure Pharmaceuticals
01 1TRIMETHOBENZAMIDE HYDROCHLORIDE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-08-19
Pay. Date : 2013-07-05
DMF Number : 26950
Submission : 2013-06-11
Status : Active
Type : II
20
Emcure Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is TRIMETHOBENZAMIDE HYDROCHLORIDE USP, with a corresponding US DMF Number 26950.
Remarkably, this DMF maintains an Active status since its submission on June 11, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 19, 2013, and payment made on July 05, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
